α-Santalol, a skin cancer chemopreventive agent with potential to target various pathways involved in photocarcinogenesis

Photochemistry and Photobiology

Volumn 89, Issue 4, 2013, Pages 919-926

  Santha, Sreevidya ^a   Dwivedi, Chandradhar ^a  

^a SOUTH DAKOTA STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CASPASE 3; CYCLOOXYGENASE 2; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE; PARP1 PROTEIN, MOUSE; PTGS2 PROTEIN, MOUSE; SANTALOL; SESQUITERPENE;

ANIMAL; ARTICLE; CELL CYCLE; CELL PROLIFERATION; DRUG EFFECT; FEMALE; GENE EXPRESSION REGULATION; GENETICS; HAIRLESS MOUSE; METABOLISM; MOUSE; PHYSIOLOGY; SKIN TUMOR; ULTRAVIOLET RADIATION;

ANIMALS; CASPASE 3; CELL CYCLE; CELL PROLIFERATION; CYCLOOXYGENASE 2; FEMALE; GENE EXPRESSION REGULATION; MICE; MICE, HAIRLESS; POLY(ADP-RIBOSE) POLYMERASES; SESQUITERPENES; SKIN NEOPLASMS; ULTRAVIOLET RAYS;

MUS;

EID: 84879815166     PISSN: 00318655     EISSN: 17511097     Source Type: Journal    
DOI: 10.1111/php.12070     Document Type: Article

References (36)

1. Bowden, G. T., (2004) Prevention of non-melanoma skin cancer by targeting ultraviolet-B-light signalling. Nat. Rev. Cancer 4, 23-35.
2. Afaq, F., V. M. Adhami, and, H. Mukhtar, (2005) Photochemoprevention of ultraviolet B signaling and photocarcinogenesis. Mutat. Res. 571, 153-173.
3. Katiyar, S. K., N. J. Korman, H. Mukhtar, and, R. Agarwal, (1997) Protective effects of silymarin against photocarcinogenesis in a mouse skin model. J. Natl Cancer Inst. 89, 556-565.
4. Ananthaswamy, H. N., and, W. E. Pierceall, (1990) Molecular mechanisms of ultraviolet radiation carcinogenesis. Photochem. Photobiol. 52, 1119-1136.
5. Matsumura, Y., and, H. N. Ananthaswamy, (2004) Toxic effects of ultraviolet radiation on the skin. Toxicol. Appl. Pharmacol. 195, 298-308.
6. 2 phase cell cycle arrest in human skin following UV irradiation. Oncogene 20, 6103-6110.
7. Siegel, R. E., O. Ward Brawley, and, A. Jemal, (2011) Cancer statistics, 2011: The impact of eliminating socioeconomic and racial disparities on premature cancer deaths. CA Cancer J. Clin. 61, 212-236.
8. Rogers, H. W., M. A. Weinstock, A. R. Harris, M. R. Hinckley, S. R. Feldman, A. B. Fleischer, and, B. M. Coldiron, (2010) Incidence estimate of nonmelanoma skin cancer in the United States, 2006. Arch. Dermatol. 146, 283-287.
9. Zhang, X., and, C. Dwivedi, (2011) Skin cancer chemoprevention by α-santalol. Front. Biosci (Schol Ed) 3, 777-787.
10. Burdock, G. A., and, I. G. Carabin, (2008) Safety assessment of sandalwood oil (Santalum album L). Food Chem. Toxicol. 46, 421-432.
11. Dwivedi, C., X. Guan, W. L. Harmsen, A. L. Voss, D. E. Goetz-Parten, E. M. Koopman, K. M. Johnson, H. B. Valluri, and, D. P. Matthees, (2003) Chemopreventive effects of α-santalol on skin tumor development in CD-1 and SENCAR mice. Cancer Epidemiol. Biomarkers Prev. 12, 151-156.
12. Dwivedi, C., H. B. Valluri, X. Guan, and, R. Agarwal, (2006) Chemopreventive effects of α-santalol on ultraviolet B radiation-induced skin tumor development in SKH-1 hairless mice. Carcinogenesis 27, 1917-1922.
13. Ferreira, C. G., M. Epping, F. A. Kruyt, and, G. Giaccone, (2002) Apoptosis: Target of cancer therapy. Clin. Cancer Res. 8, 2024-2034.
14. Shapiro, G. I., and, J. W. Harper, (1999) Anticancer drug targets: Cell cycle and checkpoint control. J. Clin Invest. 104, 1645-1653.
15. Sun, S. Y., N. Hail Jr, and, R. Lotan, (2004) Apoptosis as a novel target for cancer chemoprevention. J. Natl Cancer Inst. 96, 662-672.
16. Kaur, M., C. Agarwal, R. P. Singh, C. Dwivedi, and, R. Agarwal, (2005) Skin cancer chemopreventive agent, α-santalol, induces apoptotic death of human epidermoid carcinoma A431 cells via caspase activation together with dissipation of mitochondrial membrane potential and cytochrome c release. Carcinogenesis 26, 369-380.
17. 2/M cell cycle arrest in both p53-mutated human epidermoid carcinoma A431 cells and p53 wild-type human melanoma UACC-62 cells. BMC Res Notes. 3, 220.
18. Lu, Y. P., Y. R. Lou, J. G. Xie, Q. Y. Peng, J. Liao, C. S. Yang, M. T. Huang, and, A. H. Conney, (2002) Topical applications of caffeine or (-)-epigallocatechin gallate (EGCG) inhibit carcinogenesis and selectively increase apoptosis in UVB-induced skin tumors in mice. Proc. Natl Acad. Sci U S A. 99, 12455-12460.
19. Gu, M., R. P. Singh, S. Dhanalakshmi, C. Agarwal, and, R. Agarwal, (2007) Silibinin inhibits inflammatory and angiogenic attributes in photocarcinogenesis in SKH-1 hairless mice. Cancer Res. 67, 3483-3491.
20. Howes, M. J., M. S. Simmonds, and, G. C. Kite, (2004) Evaluation of the quality of sandalwood essential oils by gas chromatography-mass spectrometry. J. Chromatogr. A 1028, 307-312.
21. Vaid, M., S. D. Sharma, and, S. K. Katiyar, (2010) Honokiol, a phytochemical from the Magnolia plant, inhibits photocarcinogenesis by targeting UVB-induced inflammatory mediators and cell cycle regulators: Development of topical formulation. Carcinogenesis 31, 2004-2011.
22. Hong, J. T., E. J. Kim, K. S. Ahn, K. M. Jung, Y. P. Yun, Y. K. Park, and, S. H. Lee, (2001) Inhibitory effect of glycolic acid on ultraviolet-induced skin tumorigenesis in SKH-1 hairless mice and its mechanism of action. Mol. Carcinog. 31, 152-160.
23. Mueller, P. R., T. R. Coleman, A. Kumagai, and, W. G. Dunphy, (1995) Myt1: A membrane-associated inhibitory kinase that phosphorylates cdc2 on both threonine-14 and tyrosine-15. Science 270, 86-90.
24. Gautier, J., M. J. Solomon, R. P. Booher, J. F. Bazan, and, M. W. Kirschner, (1991) Cdc25 is a specific tyrosine phosphatase that directly activates p34cdc2. Cell 67, 197-211.
25. Vermeulen, K., D. R. Van Bockstaele, and, Z. N. Berneman, (2003) The cell cycle: A review of regulation, deregulation and therapeutic targets in cancer. Cell Prolif. 36, 131-149.
26. El-Deiry, W. S., T. Tokino, V. E. Velculescu, D. B. Levy, R. Parsons, J. M. Trent, D. Lin, W. E. Mercer, K. W. Kinzler, and, B. Vogelstein, (1993) WAF1, a potential mediator of p53 tumor suppression. Cell 75, 817-825.
27. Dwivedi, C., E. R. Maydew, J. J. Hora, D. M. Ramaekar, and, X. Guan, (2005) Chemopreventive effects of various concentrations of α-santalol on skin cancer development in CD-1 mice. Eur. J. Cancer Prev. 14, 473-476.
28. Bommareddy, A., J. Hora, B. Cornish, and, C. Dwivedi, (2007) Chemoprevention by alpha-santalol on UVB radiation-induced skin tumor development in mice. Anticancer Res. 27, 2185-2188.
29. Maga, G., and, U. Hubscher, (2003) Proliferating cell nuclear antigen (PCNA): A dancer with many partners. J. Cell Sci. 116, 3051-3060.
30. Weigel, M. T., and, M. Dowsett, (2010) Current and emerging biomarkers in breast cancer: Prognosis and prediction. Endocr. Relat. Cancer 17, R245-R262.
31. Franquemont, D., and, H. F. Frierson, (1995) Proliferating cell nuclear antigen immunoreactivity and prognosis of gastrointestinal stromal tumors. Mod. Pathol. 5, 473-477.
32. Mukhtar, H., and, C. A. Elmets, (1996) Photocarcinogenesis: Mechanisms, models and human health implications. Photochem. Photobiol. 63, 355-447.
33. Michalides, R. J., (1999) Cell cycle regulators: Mechanisms and their role in aetiology, prognosis, and treatment of cancer. J. Clin. Pathol. 52, 555-568.
34. Megyesi, J., N. Udvarhelyi, R. L. Safirstein, and, P. M. Price, (1996) The p53-independent activation of transcription of p21 WAF1/CIP1/SDI1 after acute renal failure. Am. J. Physiol. 1, 1211-1216.
35. Elmore, S., (2007) Apoptosis: A review of programmed cell death. Toxicol. Pathol. 35, 495-516.
36. Slee, E., A. Adrain, and, S. J. Martin, (2001) Executioner caspase-3, -6, and -7 perform distinct, non-redundant roles during the demolition phase of apoptosis. J. Biol. Chem. 276, 7320-7326.